Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Solventum Intellectual Properties Campany holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action for this entity. This workload is managed by 1 distinct examiner and 1 distinct art unit, reflecting a singular point of activity for the company's current patent prosecution. Such a focused profile is typical for entities that are navigating the patenting process for a specific pharmaceutical or biotechnological innovation.
KETCHAM, KAREN A is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. This number matches the total 1 pending office action for the company, meaning this examiner is the sole official currently reviewing the company's pending applications. The use of 1 distinct art unit further emphasizes the specific technical focus of the company's active filings. Practitioners should be aware that the company's current prosecution progress is entirely dependent on the review of this 1 examiner within the biotechnology field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KETCHAM, KAREN A | 1 | 19.6% | +37.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17630032 | ANTIMICROBIAL COMPOSITIONS AND ARTICLES COMPRISING THE SAME | KETCHAM, KAREN A | 56d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17630032 | ANTIMICROBIAL COMPOSITIONS AND ARTICLES COMPRISING THE SAME | KETCHAM, KAREN A | 56d overdue |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17630032 | ANTIMICROBIAL COMPOSITIONS AND ARTICLES COMPRISING THE SAME | KETCHAM, KAREN A | 1614 | §103 | Final Rejection | 56d overdue | Pending | Jan 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSolventum Intellectual Properties Campany has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Karen A Ketcham has the most, with 1 of Solventum Intellectual Properties Campany's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
